Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Tools & Technology › PCR › Scope Fluidics Subsidiary Developing 15-Minute PCR System for POC Infectious Disease MDx

Scope Fluidics Subsidiary Developing 15-Minute PCR System for POC Infectious Disease MDx

Sep 13, 2019
|
Madeleine Johnson
Premium

NEW YORK – Warsaw, Poland-based technology hub Scope Fluidics hopes to make a mark in the point-of-care molecular diagnostics market by providing the industry's fastest highly multiplexed sample-to-answer PCR-based system.

Through its wholly owned subsidiary, Curiosity Diagnostics, its PCR ONE system boasts detection of up to 20 targets from raw sample with a total turnaround time of 15 minutes, and an initial menu including multiplexed tests for methicillin-resistant Staphylococcus aureus (MRSA) and Clostridium difficile. 

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.
Mar
18
Featured Webinar

Molecular Multi-Target Assay Design Coupled with Reflex Testing with SARS-CoV-2 Mutations in Mind

Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Mar
29
Featured Webinar

Think Globally, Act Locally: The Importance of Coordinated Global and Community Genetic Surveillance Programs

Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.

Mar
31
Featured Webinar

Development and Commercialization of a Novel CRISPR-Based SARS CoV-2 Test

Sponsored by
MilliporeSigma

This webinar will outline the development and commercialization journey of a novel CRISPR-based SARS-CoV-2 test. 

Apr
06
Featured Webinar

Reducing COVID-19 Infections Rates at a University Campus with Mass Screening

Sponsored by
Beckman Coulter

In this webinar session, Dr. David Harris and Dr. Ryan Sprissler, who led the student and employee testing program at University of Arizona, will discuss how the university has remained physically open with nearly 25 percent of its population on campus, while keeping infection rates below 2 percent.

What's Popular?

In PCR

  1. Cue Health Over-the-Counter COVID-19 Test Gets FDA Emergency Use Authorization

  2. Abbott Gets FDA EUA for Test That Detects Coronavirus, Three Other Respiratory Infections

  3. Fulgent Genetics Aims to Use COVID-19 Testing Gains to Grow Clinical Sequencing Business

    Premium

  4. Luminex Obtains FDA Emergency Use Authorization for Expanded Respiratory Panel With SARS-CoV-2

  5. FDA Grants Emergency Use Authorization for University of Illinois Coronavirus PCR Test

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.